Published in J Immunol on December 01, 2002
The mammalian target of rapamycin: linking T cell differentiation, function, and metabolism. Immunity (2010) 2.85
Mechanisms maintaining peripheral tolerance. Nat Immunol (2009) 2.14
Anergic T cells are metabolically anergic. J Immunol (2009) 2.12
mTOR: taking cues from the immune microenvironment. Immunology (2009) 1.38
mTOR at the crossroads of T cell proliferation and tolerance. Semin Immunol (2007) 1.22
Naive CD4 t cell proliferation is controlled by mammalian target of rapamycin regulation of GRAIL expression. J Immunol (2009) 0.95
IL-2 signaling prevents T cell anergy by inhibiting the expression of anergy-inducing genes. Mol Immunol (2008) 0.94
A kinase-dead knock-in mutation in mTOR leads to early embryonic lethality and is dispensable for the immune system in heterozygous mice. BMC Immunol (2009) 0.89
Cell cycle progression following naive T cell activation is independent of Jak3/common gamma-chain cytokine signals. J Immunol (2009) 0.89
The role and regulation of mTOR in T-lymphocyte function. Arch Immunol Ther Exp (Warsz) (2012) 0.88
Induction and stability of the anergic phenotype in T cells. Semin Immunol (2013) 0.87
Casitas B-lineage lymphoma b inhibits antigen recognition and slows cell cycle progression at late times during CD4+ T cell clonal expansion. J Immunol (2008) 0.84
The SCHOOL of nature: I. Transmembrane signaling. Self Nonself (2010) 0.82
Monoallelic germline TSC1 mutations are permissive for T lymphocyte development and homeostasis in tuberous sclerosis complex individuals. PLoS One (2014) 0.75
IL-7 and IL-15 instruct the generation of human memory stem T cells from naive precursors. Blood (2012) 3.02
Extracellular HMGB1, a signal of tissue damage, induces mesoangioblast migration and proliferation. J Cell Biol (2004) 2.75
Prolonged TCR/CD28 engagement drives IL-2-independent T cell clonal expansion through signaling mediated by the mammalian target of rapamycin. J Immunol (2006) 1.81
IL-7 and IL-15 allow the generation of suicide gene-modified alloreactive self-renewing central memory human T lymphocytes. Blood (2008) 1.55
Inhibition of macrophage migration inhibitory factor (MIF) tautomerase and biological activities by acetaminophen metabolites. Proc Natl Acad Sci U S A (2002) 1.55
IL-17 protects T cells from apoptosis and contributes to development of ALPS-like phenotypes. Blood (2013) 1.48
Expression of fatty acid amide hydrolase (FAAH) in human, mouse, and rat urinary bladder and effects of FAAH inhibition on bladder function in awake rats. Eur Urol (2011) 1.46
Perioperative betamethasone treatment reduces signs of bladder dysfunction in a rat model for neurapraxia in female urogenital surgery. Eur Urol (2012) 1.37
Modulation of the triggering receptor expressed on the myeloid cell type 1 pathway in murine septic shock. Infect Immun (2006) 1.20
Targeting TNF-α to neoangiogenic vessels enhances lymphocyte infiltration in tumors and increases the therapeutic potential of immunotherapy. J Immunol (2012) 1.17
Involvement of Prep1 in the alphabeta T-cell receptor T-lymphocytic potential of hematopoietic precursors. Mol Cell Biol (2005) 1.17
Autonomic denervation of lymphoid organs leads to epigenetic immune atrophy in a mouse model of Krabbe disease. J Neurosci (2007) 1.17
The soluble D2D3(88-274) fragment of the urokinase receptor inhibits monocyte chemotaxis and integrin-dependent cell adhesion. J Cell Sci (2004) 1.14
Reduced functional avidity promotes central and effector memory CD4 T cell responses to tumor-associated antigens. J Immunol (2010) 1.12
Targeted inactivation of the COP9 signalosome impairs multiple stages of T cell development. J Exp Med (2008) 1.08
Changes in the immune responses against human herpesvirus-8 in the disease course of posttransplant Kaposi sarcoma. Transplantation (2008) 1.06
The tuberous sclerosis complex: balancing proliferation and survival. Biochem Soc Trans (2011) 1.01
VDR-dependent regulation of mast cell maturation mediated by 1,25-dihydroxyvitamin D3. J Leukoc Biol (2006) 1.00
Reticulocyte parameters: markers of early response to oral treatment in children with severe iron-deficiency anemia. J Pediatr Hematol Oncol (2012) 0.96
Critical impact of the kinetics of dendritic cells activation on the in vivo induction of tumor-specific T lymphocytes. Cancer Res (2003) 0.95
Prostate cancer stem cells are targets of both innate and adaptive immunity and elicit tumor-specific immune responses. Oncoimmunology (2013) 0.93
Vascular targeting, chemotherapy and active immunotherapy: teaming up to attack cancer. Trends Immunol (2008) 0.93
Booster vaccinations against cancer are critical in prophylactic but detrimental in therapeutic settings. Cancer Res (2013) 0.93
A signaling loop of REST, TSC2 and β-catenin governs proliferation and function of PC12 neural cells. J Cell Sci (2011) 0.90
Vaccine-instructed intratumoral IFN-γ enables regression of autochthonous mouse prostate cancer in allogeneic T-cell transplantation. Cancer Res (2013) 0.87
Cytosolic sequestration of Prep1 influences early stages of T cell development. PLoS One (2008) 0.86
Phenotype and homing of CD4 tumor-specific T cells is modulated by tumor bulk. J Immunol (2005) 0.85
Rapamycin-sensitive signals control TCR/CD28-driven Ifng, Il4 and Foxp3 transcription and promoter region methylation. Eur J Immunol (2011) 0.85
IL-7 is superior to IL-2 for ex vivo expansion of tumour-specific CD4(+) T cells. Eur J Immunol (2010) 0.84
The fatty acid amide hydrolase inhibitor oleoyl ethyl amide counteracts bladder overactivity in female rats. Neurourol Urodyn (2013) 0.83
Spinal cord FAAH in normal micturition control and bladder overactivity in awake rats. J Urol (2012) 0.82
Concurrent allorecognition has a limited impact on posttransplant vaccination. J Immunol (2011) 0.82
Constitutive active p21ras enhances primary T cell responsiveness to Ca2+ signals without interfering with the induction of clonal anergy. Eur J Immunol (2002) 0.81
TCR gene-engineered T cell: limited T cell activation and combined use of IL-15 and IL-21 ensure minimal differentiation and maximal antigen-specificity. Mol Immunol (2010) 0.81
Effects on bladder function of combining elocalcitol and tolterodine in rats with outflow obstruction. BJU Int (2012) 0.80
Naftopidil for the treatment of benign prostate hyperplasia: a systematic review. Curr Med Res Opin (2013) 0.80
Tumor-targeting vaccination instructs graft-vs.-tumor immune responses. Oncoimmunology (2013) 0.79
Concomitant tumor and minor histocompatibility antigen-specific immunity initiate rejection and maintain remission from established spontaneous solid tumors. Cancer Res (2010) 0.79
Effects of the gonadotropin-releasing hormone antagonist ganirelix on normal micturition and prostaglandin E(2)-induced detrusor overactivity in conscious female rats. Eur Urol (2010) 0.79
Synthetic CD4+ T cell-targeted antigen-presenting cells elicit protective antitumor responses. Cancer Res (2008) 0.78
Targeting FR-expressing cells in ovarian cancer with Fab-functionalized nanoparticles: a full study to provide the proof of principle from in vitro to in vivo. Nanoscale (2015) 0.76
Transplant Site Influences the Immune Response After Islet Transplantation: Bone Marrow Versus Liver. Transplantation (2017) 0.76
Immune surveillance and anti-tumor immune responses: an anatomical perspective. Immunol Lett (2005) 0.76
Antigen-experienced CD4(+) T cells limit naïve T-cell priming in response to therapeutic vaccination in vivo. Cancer Res (2010) 0.76
Absence of Rac1 and Rac3 GTPases in the nervous system hinders thymic, splenic and immune-competence development. Eur J Immunol (2011) 0.75
The immunogenicity of dendritic cell-based vaccines is not hampered by doxorubicin and melphalan administration. J Immunol (2005) 0.75
Trick to treat: tricking the thymus to treat cancer. Blood (2013) 0.75
Tumors hamper the immunogenic competence of CD4+ T cell-directed dendritic cell vaccination. J Immunol (2007) 0.75